Presentation TCT 2017 Debate: After PCI in ACS, Should DAPT Potency Be De-escalated Over Time? Yes, Based on TROPICAL-ACS, TRITON, and Other Studies! Presenter: John A. Bittl, Freek W.A. Verheugt, Dirk Sibbing October 30, 2017
Presentation TCT 2017 Should Choice of Parenteral Therapy for Primary PCI in STEMI Depend on Vascular Access? Presenter: Michael S. Lee, Dirk Sibbing, John A. Bittl October 30, 2017
Presentation TCT 2017 Parenteral Therapy in STEMI: Does VALIDATE Change the Equation? Presenter: Michael S. Lee, Dirk Sibbing, David Erlinge October 30, 2017
Presentation TCT 2017 Why I Use Cangrelor for Primary PCI in STEMI! Presenter: Michael S. Lee, Dirk Sibbing, Dmitriy N. Feldman October 30, 2017
Presentation TCT 2017 Why I Prefer Bivalirudin for Primary PCI in STEMI! Presenter: Michael S. Lee, Dirk Sibbing, Uwe Zeymer October 30, 2017
Presentation TCT 2017 Why I Prefer a Heparin Plus a GPI for Primary PCI in STEMI! Presenter: Michael S. Lee, Dirk Sibbing, Eric R. Bates October 30, 2017
Presentation TCT 2017 Why I Prefer Unfractionated Heparin Without GPI for Primary PCI in STEMI! Presenter: Michael S. Lee, Dirk Sibbing, A. Michael Lincoff October 30, 2017
Presentation TCT 2017 STEMI Case Presentation: Why the Choice of Patental Therapy Matters Presenter: Michael S. Lee, Dirk Sibbing, Francesco Franchi October 30, 2017
News Conference News ESC 2017 DAPT Can Be Safely De-Escalated Post-PCI Based on Platelet Function Testing Todd Neale September 07, 2017